Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer
Cancer Letters · 2023-06 · 564 · 216205
DOI: 10.1016/j.canlet.2023.216205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023-06. Verfasst von Jiaye Lu und 16 weiteren Autor:innen. Beteiligte Einrichtung: National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, …. Hauptthemen laut MEDLINE: ErbB Receptors, Lung Neoplasms. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National-Local Joint Engineering Laboratory of Draggability and New Drug Evaluation, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou,…
- Department of Thoracic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
- Increasepharm (Hengqin) Innovative Medicine Institute Co. Ltd, Zhuhai, 519000, China.
- Department of Medicine, Division of Hematology-Oncology, and Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, 519000, Macau. Electronic address: jinjianlu@umac.mo.
- Department of Thoracic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. Electronic address: sumszhangjian@163.com.
Zitieren
APA
Lu, J., Li, J., Lin, Z., Li, H., Lou, L., Ding, W., Ouyang, S., Wu, Y., Wen, Y., Chen, X., Yue, P., Wang, Y., Liu, P., Lu, J., Zhang, J., Feng, W., & Zhang, X. (2023). Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer. Cancer Letters, 564, 216205. https://doi.org/10.1016/j.canlet.2023.216205
Vancouver
Lu J, Li J, Lin Z, Li H, Lou L, Ding W, et al. Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer. Cancer Letters. 2023;564:216205. doi:10.1016/j.canlet.2023.216205
BibTeX
@article{Lu2023,
author = {Lu, Jiaye and Li, Jingwei and Lin, Ziyou and Li, Huaxuan and Lou, Linlin and Ding, Wen and Ouyang, Shumin and Wu, Yonghui and Wen, Yuanzhen and Chen, Xiaobing and Yue, Peibin and Wang, Yuanxiang and Liu, Peiqing and Lu, Jinjian and Zhang, Jian and Feng, Weineng and Zhang, Xiaolei},
title = {Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer},
journal = {Cancer Letters},
year = {2023},
volume = {564},
pages = {216205},
doi = {10.1016/j.canlet.2023.216205}
}
EUVIMED